These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 9463805)
41. A reformative shear precipitation procedure for the fabrication of vancomycin-loaded poly(lactide-co-glycolide) microspheres. Wang L; Yang Q; Chen Y; Chai Y; Li JJ; Du L; Tan R; Yang S; Tu M; Yu B J Biomater Appl; 2017 Feb; 31(7):995-1009. PubMed ID: 28068861 [TBL] [Abstract][Full Text] [Related]
42. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277 [TBL] [Abstract][Full Text] [Related]
43. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Roullin VG; Deverre JR; Lemaire L; Hindré F; Venier-Julienne MC; Vienet R; Benoit JP Eur J Pharm Biopharm; 2002 May; 53(3):293-9. PubMed ID: 11976017 [TBL] [Abstract][Full Text] [Related]
44. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Prior S; Gamazo C; Irache JM; Merkle HP; Gander B Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713 [TBL] [Abstract][Full Text] [Related]
45. Encapsulation of azithromycin into polymeric microspheres by reduced pressure-solvent evaporation method. Li X; Chang S; Du G; Li Y; Gong J; Yang M; Wei Z Int J Pharm; 2012 Aug; 433(1-2):79-88. PubMed ID: 22583850 [TBL] [Abstract][Full Text] [Related]
46. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704 [TBL] [Abstract][Full Text] [Related]
48. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541 [TBL] [Abstract][Full Text] [Related]
49. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. Gabor F; Ertl B; Wirth M; Mallinger R J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498 [TBL] [Abstract][Full Text] [Related]
50. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Wang J; Wang BM; Schwendeman SP Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856 [TBL] [Abstract][Full Text] [Related]
51. PLG microsphere size controls drug release rate through several competing factors. Berkland C; Kim K; Pack DW Pharm Res; 2003 Jul; 20(7):1055-62. PubMed ID: 12880292 [TBL] [Abstract][Full Text] [Related]
52. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study. Peng YJ; Kau YC; Wen CW; Liu KS; Liu SJ J Biomed Mater Res A; 2010 Aug; 94(2):426-32. PubMed ID: 20186737 [TBL] [Abstract][Full Text] [Related]
53. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination. Giunchedi P; Conti B; Scalia S; Conte U J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429 [TBL] [Abstract][Full Text] [Related]
54. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. Ertl B; Platzer P; Wirth M; Gabor F J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803 [TBL] [Abstract][Full Text] [Related]
55. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis. Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425 [TBL] [Abstract][Full Text] [Related]
56. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Ibrahim MA; Ismail A; Fetouh MI; Göpferich A J Control Release; 2005 Sep; 106(3):241-52. PubMed ID: 15970349 [TBL] [Abstract][Full Text] [Related]
57. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks. Ozalp Y; Ozdemir N; Hasirci V J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762 [TBL] [Abstract][Full Text] [Related]
58. Preparation of amifostine polylactide-co-glycolide microspheres and its irradiation protective to mouse through oral administration. Lu TL; Sun WG; Zhao W; Chen T Drug Dev Ind Pharm; 2011 Dec; 37(12):1473-80. PubMed ID: 21721846 [TBL] [Abstract][Full Text] [Related]
59. The fate of biodegradable microspheres injected into rat brain. Nicholas AP; McInnis C; Gupta KB; Snow WW; Love DF; Mason DW; Ferrell TM; Staas JK; Tice TR Neurosci Lett; 2002 Apr; 323(2):85-8. PubMed ID: 11950499 [TBL] [Abstract][Full Text] [Related]